Kevin A. Adamzek

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.

Journal: European journal of nuclear medicine and molecular imaging
Published: April 17, 2024

Learning, memory and blood-brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140.

Learning, memory and blood-brain barrier pathology in Duchenne muscular dystrophy mice lacking Dp427, or Dp427 and Dp140.

Journal: Genes, brain, and behavior
Published: November 16, 2023

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.

Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.

Journal: Theranostics
Published: December 24, 2020

Premature termination codons in the DMD gene cause reduced local mRNA synthesis.

Premature termination codons in the DMD gene cause reduced local mRNA synthesis.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: July 04, 2020

First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs).

First platinum(II)-based metal-organic linker technology (Lx®) for a plug-and-play development of antibody-drug conjugates (ADCs).

Journal: Expert opinion on drug delivery
Published: July 23, 2019

A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.

A modified diet does not ameliorate muscle pathology in a mouse model for Duchenne muscular dystrophy.

Journal: PloS one
Published: January 11, 2019

Fully Automated 89Zr Labeling and Purification of Antibodies.

Fully Automated 89Zr Labeling and Purification of Antibodies.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 05, 2018

A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab.

A Novel Platinum(II)-Based Bifunctional ADC Linker Benchmarked Using 89Zr-Desferal and Auristatin F-Conjugated Trastuzumab.

Journal: Cancer research
Published: July 19, 2016

Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET.

Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET.

Journal: European journal of nuclear medicine and molecular imaging
Published: July 15, 2016

Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts.

Development of [11C]vemurafenib employing a carbon-11 carbonylative Stille coupling and preliminary evaluation in mice bearing melanoma tumor xenografts.

Journal: Oncotarget
Published: May 17, 2016

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).

Journal: Nuclear medicine and biology
Published: June 16, 2015
Showing 1-11 of 11

Last Updated: 09/26/2026